Condensed Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 8,078	$ 1,979
General and administrative	3,576	1,918
Total operating expenses	11,654	3,897
Loss from operations	(11,654)	(3,897)
Other income (expenses):
Interest income (expense), net	1	(1)
Net loss	$ (11,653)	$ (3,898)
Per share information:
Net loss per share of common stock, Basic	$ (0.96)	$ (0.37)
Net loss per share of common stock, Diluted	$ (0.96)	$ (0.37)
Weighted average shares of common stock outstanding, Basic	12,122,903	10,640,870
Weighted average shares of common stock outstanding, Diluted	12,122,903	10,640,870